vimarsana.com
Home
Live Updates
SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer : vimarsana.com
SAB Biotherapeutics Appoints Michael G. King Jr. as Chief Financial Officer
Finance leader joins SAB with more than 25 years of experience as a leading biotech equity research analystSIOUX FALLS, S.D., Oct. 24, 2023 -- SAB Biotherapeutics, Inc. , today announced that...
Related Keywords
United States ,
America ,
Rodman Renshaw ,
Samuelj Reich ,
Robertson Stephens ,
Eddiej Sullivan ,
Russell Beyer ,
Hambrecht Quist ,
Michaelg King Jr ,
Nasdaq ,
Linkedin ,
Exchange Commission ,
Ef Hutton Group ,
Head Of Healthcare Research ,
Biotherapeutics Inc ,
Twitter ,
Chief Financial ,
Alex Brown ,
Vector Securities ,
Healthcare Research ,
City University ,
Chief Executive Officer ,
Chairman Samuel ,
Private Securities Litigation Reform Act ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.